Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Brain (and spinal cord) tumours
Closed
Phase 1/2
This trial is looking at olaparib and radiotherapy for people with a type of brain tumour called a glioblastoma who cannot have standard treatment. This includes people over the age of 65 and younger people who have poor health.
Please note, the sub study is open to recruitment. The main study is closed. You can find out about the sub study in the trial design section below.
Cancer Research UK supports this trial.
Recruitment start: 3 March 2015
Recruitment end: 31 March 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Anthony Chalmers
AstraZeneca
Cancer Clinical Trials Unit Scotland
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NHS Greater Glasgow & Clyde
NIHR Clinical Research Network: Cancer
University of Glasgow
This is Cancer Research UK trial number CRUK/13/034.
Last reviewed: 31 Mar 2025
CRUK internal database number: 11764